These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5985204)

  • 1. [The endogenic and exogenic fibrinolytic activity of the blood in arteriovascular diseases].
    Perlick E; Wilfert K; Zimmermann J; Vitzthum HE
    Z Gesamte Inn Med; 1966 Apr; 21(7):198-201. PubMed ID: 5985204
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolysis and vascular diseases].
    Udvardy M; Boda Z
    Orv Hetil; 1996 Aug; 137(34):1851-5. PubMed ID: 8927337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet function, blood lipid, coagulation and fibrinolysis in diabetic and nondiabetic patients with arteriosclerosis].
    Nagakawa Y; Orimo H; Harasawa M; Sawada T
    Nihon Ronen Igakkai Zasshi; 1985 Jan; 22(1):13-9. PubMed ID: 4010029
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coagulative and fibrinolytic blood activity in diabetic angiopathy (author's transl)].
    Kaniak J; Kurzawska M; Kotschy M; Paczyńska D; Moszczynska D; Prastowski W; Kozlowska B; Czarnacki M
    Przegl Lek; 1977; 34(6):527-33. PubMed ID: 905590
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gas-chromatography study of plasmatic fatty acids in diabetic and arteriosclerotic vascular diseases].
    Vitelli A; Cattaneo C; Saiani A; Martino P
    Minerva Cardioangiol; 1967 Aug; 15(8):509-16. PubMed ID: 5605036
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinolytic activity and platelet aggregation as risk factors in the progression of diabetic macroarteriopathy of the lower extremities].
    McCook Martínez J; Corral Almonte JF; González Sosa IP; Cruz Gómez Y
    Angiologia; 1980; 32(5):221-7. PubMed ID: 7425388
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of coagulation-fibrinolytic system in diabetic vascular complications. Part II: Involvement of coagulation-fibrinolytic system in diabetic vascular complications.
    Hoshiyama M
    Nihon Ketsueki Gakkai Zasshi; 1980 Aug; 43(4):723-9. PubMed ID: 7223337
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rheologic changes in subjects with vascular pathology].
    Savi L; Cardillo C; Melina D; Guerrera G
    Minerva Cardioangiol; 1985 Sep; 33(9):523-8. PubMed ID: 4088479
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].
    Udvardy M; Pósán E
    Orv Hetil; 1994 Sep; 135(37):2025-7. PubMed ID: 7936609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation and fibrinolytic parameters in patients with various angiopathies--analysis in cerebral thrombosis, diabetic and vasculitic neuropathies].
    Kohriyama T; Katayama S; Tanaka E; Yamamura Y; Nakamura S
    Rinsho Shinkeigaku; 1993 Jun; 33(6):606-11. PubMed ID: 8403679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW; Catto AJ; Carter AM; Grant PJ
    Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate.
    Earle KA; Mattock M; Morocutti A; Aravanitis D; Viberti GC
    Diabet Med; 1996 Dec; 13(12):1071-2. PubMed ID: 8973890
    [No Abstract]   [Full Text] [Related]  

  • 13. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrinolytic activity of the blood in atherosclerosis].
    Katalin Z; László K; Agnes F
    Orv Hetil; 1970 Jul; 111(27):1579-80. PubMed ID: 5454464
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipoproteins as risk factors for vascular disease in diabetes.
    Brown WV; Bloomgarden Z; Ginsberg H
    Mt Sinai J Med; 1982; 49(3):176-86. PubMed ID: 6981757
    [No Abstract]   [Full Text] [Related]  

  • 16. The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
    Fuller JH
    Ann Clin Res; 1984; 16(3):137-41. PubMed ID: 6236737
    [No Abstract]   [Full Text] [Related]  

  • 17. [Apolipoproteins as risk factors of atherosclerosis].
    Dargel R; Winkler L
    Z Med Lab Diagn; 1989; 30(1):35-6. PubMed ID: 2718575
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombosis and diabetic angiopathy].
    Dupuy E; Guillausseau PJ; Lubetzki J
    Nouv Rev Fr Hematol (1978); 1982; 24(3):173-7. PubMed ID: 6215622
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
    Skrha J; Hodinár A; Kvasnicka J; Hilgertová J
    Diabet Med; 1996 Sep; 13(9):800-5. PubMed ID: 8891455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.